HIGHLIGHTS OF LESSONS LEARNED DURING THE LAST 12 YEARS OF PROTEIN STRUCTURE-BASED DRUG DESIGN.

Mike Varney
Agouron Pharmaceuticals, Inc.




The presentation will describe many of the strengths, limitations, pitfalls and other lessons learned using protein structures to design therapeutically useful drug candidates. Where possible, real life examples will be used to illustrate particular points. The talk is organized using small sometimes-provocative phrases or statements of lessons learned followed by an example where the lesson can be clearly seen. One of the key points of the presentation will illustrate that lessons learned in one project can be generalized to other projects.